Atlas Trials

A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort Pharmacokinetics

Clinical trial NCT02286609 · COMPLETED

Trial details

NCT number
NCT02286609
Sponsor
PTC Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2014-12-01
Primary completion
2015-02-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.